David Venables
Chief Executive Officer at Synpromics Ltd.
David Venables active positions
Companies | Position | Start | End |
---|---|---|---|
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Chief Executive Officer | - | - |
Director/Board Member | 14/12/2014 | 06/08/2019 | |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | Director/Board Member | - | - |
Chief Executive Officer | 31/07/2021 | - |
Career history of David Venables
Former positions of David Venables
Companies | Position | Start | End |
---|---|---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Director/Board Member | 01/08/2012 | 26/02/2015 |
Corporate Officer/Principal | 15/04/2012 | 01/08/2012 | |
ANATARA LIFESCIENCES LTD | Director/Board Member | 16/02/2014 | 23/02/2015 |
Chief Executive Officer | 16/02/2014 | 23/02/2015 | |
Q-One Biotech Ltd. | Corporate Officer/Principal | - | - |
Medeva Plc | Corporate Officer/Principal | - | - |
IOMAI CORPORATION | Chief Operating Officer | - | - |
Training of David Venables
University of Surrey | Doctorate Degree |
Statistics
International
United Kingdom | 7 |
United States | 2 |
Australia | 2 |
Operational
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 3 |
Sectoral
Health Technology | 6 |
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ANATARA LIFESCIENCES LTD | Health Technology |
Private companies | 6 |
---|---|
Ark Therapeutics Group Plc
Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
Medeva Plc | Health Technology |
Q-One Biotech Ltd. | Health Technology |
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Process Industries |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | Health Technology |
- Stock Market
- Insiders
- David Venables
- Experience